Home Navrogen

Navrogen

In operation
Seed Round Financing
Cancer Targeted Therapy Drug Developer
Basic
Enterprise Profile

Basic Information

Navrogen is a biopharmaceutical company focused on cancer-targeted therapies. Navrogen is currently working to enhance the immune system to combat cancer by eliminating the effects of factors produced or induced by tumor cells that suppress the anti-cancer humoral immune system. Navrogen is a leader in the field of Humoral Immuno-Oncology (HIO).
Navrogen, Inc
Pennsylvania,United States of America
less than 15 people
January 01, 2017
info@navrogen.com

Enterprise Profile

Industrial Sector
New Drug Development Biological Drug Production
Technology
Targeted Technology
Concept
Tumor Therapeutic Products
Application Scenarios
Innovative Drugs ADC (Antibody-Drug Conjugate)